Ozics

Company profile

Ozics company profile

Ozics was founded by experts in orthopaedic surgery and biomaterial science to commercialise a family of surgical implants to first address the screw purchase problems currently experienced with osteosynthesis and shortcomings in the treatment of vertebral compression fractures (VCF ). Following a successful execution of a series of clinical trials, Ozics is determined to bring to the market a minimally invasive fracture fixation system to be used in load bearing fractures, such as hip, as a stand-alone device allowing immediate unassisted mobility. Ozics’ vision is to develop a range of materials and implants that deliver the clinical benefits outlined above. The basic material is a composite of a dimethylacrylate based polymer matrix and ceramic filler, containing silicate glass and hydroxyapatite (HA). The material can be administered by injection to provide a custom-made, intra-bony implant. Used primarily as a stand-alone device, it can also be used in conjunction with other fixation approaches and devices. Ozics’ first product offering, CompO6™ reinforced bone composite, is an injectable bone cement indicated for vertebral compression fractures and to aid screw purchase in trauma procedures throughout the entire skeleton.